Skin Analytics Ltd

Skin Analytics has already developed an AI melanoma screening tool for use assessing pigmented lesions in primary care and earlier. Two additional technologies could, when coupled with our existing melanoma service, significantly improve the quality of onward referrals into secondary care and enable cost effective population based screening.

These are a non-melanoma skin cancer screening tool, and a change analysis tool. In phase 1 we will develop these tools and aim to show performance levels that indicate that a combined service product can be developed and deployed to significantly improve the skin cancer pathway (phase 2).